Harvard Findings

[Guest guest]

Something to think about that is on the horizon.

The Adult Leukemia Program provides virtually all services required by patients

with acute leukemia and related disorders. These include:

a.. evaluation and diagnosis of individuals with any type of bone-marrow

disorder, including acute and chronic leukemias, myeloproliferative disorders,

and myelodysplastic syndromes

b.. evaluation and diagnosis of patients with unexplained anemia, or abnormal

white blood or platelet counts

c.. development and implementation of a personalized treatment plan, ranging

from standard supportive care to intensive chemotherapy for acute leukemia

d.. access to new therapies through clinical research protocols

e.. comprehensive bone marrow transplantation services

f.. support services

The clinical research mission of the Adult Leukemia Program is to develop and

bring new and better therapies to patients. At any given time, the program

offers patients a wide array of opportunities to participate in clinical

research studies relating to all stages and types of leukemia and related

disorders.

http://www.dana-farber.org/pat/adult/hematologic-oncology/adult-leukemia.html

CML ENCODING GENES.

Both 8 and CML66 hold promise as targets for antigen-specific immunotherapy

in different solid tumors as well as leukemias. Comparing with other

cancer-testis (CT) antigens, 8 has wider expression pattern in a variety of

tumors. This invention provides both CML protein and gene, and methods for CML

expression, detection and modulation. For example, antibodies specific to CML

proteins are provided which are useful for the detection, prevention and

treatment of cancers. Similarly, this invention provides nucleic acids as

hybridization probes to determine the presence of CML-encoding genes. These

detection schemes are useful for both diagnostic and prognostic assays, guiding

the clinician in both therapeutic and prophylactic approaches, respectively.

http://www.dana-farber.org/res/technology/printable.asp?case_number=722

MISSION POSSIBLE had begun at Dana Farber. Boldly recognizing that the

opportunity to conquer cancer is within reach, Dana-Farber Cancer Institute has

launched a $1 billion comprehensive capital campaign - the largest and most

ambitious fundraising campaign in its history. $863 million has been raised so

far, but they still have a long way to go.

http://www.dana-farber.org/abo/mission-possible-campaign/

Blessings,

Lottie